Abstract

We determine: 1) whether the addition of asymmetric dimethylarginine (ADMA) reduces nitric oxide (NO)-related metabolites in primary airway epithelial cells under IL-13/ IFNγ stimulation, 2) supplementation of L-arginine/L-citrulline to cultures with high ADMA/iNOS expression is able to redirect iNOS towards NOx production. L-arginine and L-citrulline supplementation are able to increase the formation of NOx (nitrates + nitrates) in human airway epithelial cells, despite treatment with endogenous iNOS inhibitor ADMA. L-arginine and L-citrulline may have a therapeutic potential in diseases in which there is a defective production of NO.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.